Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-16 Purchase |
2024-12-18 4:11 pm |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
1,250,000 | $6 | $7,500,000 | 2,984,752 (Indirect Direct) |
View |
| 2024-11-22 Purchase |
2024-11-26 4:15 pm |
Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner |
22,921,348 | $0 | $0 | 60,982,127 (Indirect Direct) |
View |
| 2024-09-12 Purchase |
2024-09-16 4:05 pm |
Liquidia Corp | LQDA | Manning Paul B Director |
337,078 | $8.9 | $2,999,994 | 6,602,551 (Indirect Direct) |
View |
| 2024-06-27 Purchase |
2024-07-01 08:00 am |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B 10% Owner |
1,333,333 | $2.25 | $2,999,999 | 24,851,111 (Indirect Direct) |
View |
| 2023-12-14 Purchase |
2023-12-18 5:00 pm |
Liquidia Corp | LQDA | Manning Paul B Director |
279,330 | $7.16 | $2,000,003 | 6,245,114 (Indirect Direct) |
View |
| 2023-11-17 Purchase |
2023-11-20 07:35 am |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B 10% Owner |
100,000 | $1.63 | $163,000 | 23,517,778 (Indirect) |
View |
| 2023-08-16 Purchase |
2023-08-16 8:57 pm |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B 10% Owner |
16,466,667 | $0.9 | $14,820,000 | 23,417,778 (Indirect) |
View |
| 2023-07-24 Purchase |
2023-07-24 6:47 pm |
Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner |
200,000 | $5.02 | $1,004,000 | 15,589,481 (Indirect Direct) |
View |
| 2022-10-31 Purchase |
2022-11-02 4:09 pm |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
1,500,000 | $2 | $3,000,000 | 6,951,111 (Indirect Direct) |
View |
| 2022-07-05 Purchase |
2022-07-05 4:10 pm |
Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner |
4,761,904 | $2.1 | $9,999,998 | 15,389,481 (Indirect Direct) |
View |
| 2022-04-18 Purchase |
2022-04-19 4:30 pm |
Liquidia Corp | LQDA | Manning Paul B Director |
392,156 | $5.1 | $1,999,996 | 5,530,110 (Indirect Direct) |
View |
| 2022-02-02 Purchase |
2022-02-04 08:28 am |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
201,602 | $7.7966 | $1,571,810 | 5,429,111 (Indirect Direct) |
View |
| 2021-12-02 Purchase |
2021-12-06 08:20 am |
Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner |
50,000 | $9.3581 | $467,905 | 10,627,577 (Indirect Direct) |
View |
| 2021-11-24 Purchase |
2021-11-29 5:01 pm |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
2,202 | $13.19 | $29,044 | 5,249,509 (Indirect Direct) |
View |
| 2021-11-23 Purchase |
2021-11-24 07:58 am |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
20,000 | $12.54 | $250,800 | 5,247,307 (Indirect Direct) |
View |
| 2021-07-29 Purchase(A) |
2021-08-04 4:41 pm |
Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner |
1,625,000 | $8 | $13,000,000 | 2,234,752 (Indirect Direct) |
View |
| 2021-07-27 Purchase |
2021-07-29 9:02 pm |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
56,000 | $7.3353 | $410,778 | 56,000 (Direct) |
View |
| 2021-07-06 Purchase |
2021-07-08 6:35 pm |
Acumen Pharmaceuticals Inc. | ABOS | Manning Paul B 10% Owner |
312,500 | $16 | $5,000,000 | 657,985 (Indirect) |
View |
| 2021-05-14 Purchase |
2021-05-17 07:48 am |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
12,000 | $20.98 | $251,760 | 5,227,307 (Indirect Direct) |
View |
| 2021-04-13 Purchase |
2021-04-15 09:24 am |
Liquidia Corp | LQDA | Manning Paul B Director 10% Owner |
198,413 | $2.52 | $500,001 | 5,137,954 (Indirect) |
View |
| 2021-03-25 Purchase |
2021-03-29 09:12 am |
Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner |
739,830 | $14.75 | $10,912,493 | 10,577,577 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-26 Gift |
2024-11-26 4:15 pm |
N/A N/A |
Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner |
450,000 | $0 | 60,982,127 (Direct) |
View |
| 2024-09-19 Gift |
2024-09-23 4:15 pm |
N/A N/A |
Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner |
4,459,352 | $0 | 13,805,690 (Indirect) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:37 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 9:39 pm |
N/A N/A |
Liquidia Corp | LQDA | Manning Paul B Director |
20,359 | $0 | 6,265,473 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-19 Option Award |
2023-06-21 5:01 pm |
2026-06-19 2033-06-19 |
Liquidia Corp | LQDA | Manning Paul B Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2023-02-14 6:15 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | PD Joint Holdings LLC Series 2016-A Manning Paul B Manning Bradford Tiger Lily Capital LLC 10% Owner |
0 | $0 | 3,408,696 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:36 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:36 pm |
N/A 2032-06-17 |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
15,500 | $0 | 15,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:31 pm |
2025-06-17 2032-06-17 |
Liquidia Corp | LQDA | Manning Paul B Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership(A) |
2022-05-04 4:51 pm |
N/A N/A |
Liquidia Corp | LQDA | Manning Paul B Director 10% Owner |
0 | $0 | 479,233 (Indirect) |
View |
| 2022-03-31 Option Award |
2022-04-20 4:36 pm |
N/A N/A |
Liquidia Corp | LQDA | Manning Paul B Director |
435,674 | $0 | 5,965,784 (Indirect) |
View |
| 2021-07-06 Ownership |
2022-02-14 9:16 pm |
N/A N/A |
Liquidia Corp | LQDA | Manning Paul B Director 10% Owner |
8,381,383 | $0 | 4,658,721 (Indirect) |
View |
| 2021-07-06 Ownership |
2022-02-14 9:15 pm |
N/A N/A |
Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner |
739,830 | $0 | 8,889,224 (Indirect) |
View |
Ownership |
2022-02-14 4:37 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner |
0 | $0 | 2,877,158 (Indirect) |
View |
| 2021-07-14 Ownership |
2022-02-14 4:37 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner |
36,752 | $0 | 2,877,158 (Indirect) |
View |
| 2021-08-20 Option Award |
2021-09-01 5:24 pm |
2024-08-20 2031-08-20 |
Liquidia Corp | LQDA | Manning Paul B Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-07-29 Conversion(A) |
2021-08-04 4:41 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner |
4,263,282 | $0 | 2,234,752 (Indirect) |
View |
| 2021-07-29 Conversion |
2021-08-02 8:08 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
4,263,282 | $0 | 609,752 (Indirect) |
View |
Ownership |
2021-07-26 9:24 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
0 | $0 | 2,465,820 (Indirect) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:35 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Manning Paul B 10% Owner |
6,558,953 | $0 | 657,985 (Indirect) |
View |
Ownership |
2021-06-30 7:11 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Manning Paul B 10% Owner |
0 | $0 | 3,698,178 (Indirect) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:59 pm |
N/A 2031-06-17 |
Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner |
15,500 | $0 | 15,500 (Direct) |
View |